Anzeige
Mehr »
Lynx Broker
Login
Samstag, 14.12.2019 Börsentäglich über 12.000 News von 620 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrRoche's Tecentriq combo scores in first-line melanoma
FrHouse Democrats finally pass landmark drug pricing bill
FrUPDATED: Senate officially confirms Stephen Hahn as FDA commissioner
FrFDA grants surprise OK to Sarepta's DMD therapy after earlier rejection
FrBrexit nears as Conservatives sweep to victory in election
DoNew faces at JPA Health Communications, GCI Health and HRW
DoPharmaLex announces joint venture with Vintura
DoBiologic patent exclusivity scrapped in new US trade deal
DoAZ, Daiichi Sankyo strengthen case for HER2 candidate
DoUCB/Amgen's Evenity finally cleared for osteoporosis in Europe
DoIntec battered as Novartis ducks out of Accordion collaboration
DoJ&J appeals Oklahoma opioid verdict, claiming 'errors' in trial
MiCorrevio crumbles as FDA panel rejects AFib drug
MiBMS' oral maintenance therapy boosts survival in AML patients
MiSanofi's sutimlimab set for filing in rare autoimmune anaemia next year
MiSanofi narrows focus, shedding diabetes and cardiovascular research
MiPharma Brand Planners' Blog (Part 7)
DiJ&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data
DiRegeneron reveals first data for bispecific antibody in multiple myeloma
DiMerck buys ArQule for $2.7bn in another cancer bolt-on deal
DiJ&J splashes $750m on anti-inflammatory drug bermekimab
DiHealthcare trends 2020 - the biggest shifts changing lives and life sciences
DiSanofi's new CEO cuts first deal, adding Synthorx for $2.5bn
MoBluebird bio's sickle cell gene therapy shows early-study benefit
MoAstraZeneca's Calquence impresses in previously untreated CLL